Soluto Regulatórios acts in the orientation, analysis and preparation of dossiers for settlement products in order to ensure the viability of marketing with quality, speed and safety.
With experience in notification, cadaster and product registration at ANVISA and MAPA, Soluto Regulatórios team is competent to carry out work with all classes of products, respecting the particularities in conducting processes for each customer.
- Initial regularization of domestic and imported products
- Cadastres, registrations and notifications
- Technical framework and grouping
- Definition of strategies for product regularization
- Technical and regulatory feasibility analysis
Related articles
RDC No. 687/2022
New criteria for granting or renewing the Certification of Good Manufacturing Practices for Medical Devices. On 05/18, Resolution - RDC No. 687/2022 was published in the Official Gazette [...]
Changes in the RDCs approved during the pandemic.
Understand what changes in health legislation with the end of the emergency related to Covid-19. Check out some rules extended and revoked by the agency. After the government declared the end of [...]
Regulatory efficiency in the Importation of Essential Medicines via RDC 563 and RDC.
Understand the main criteria of exceptionality, extended by ANVISA until 03/31 to reduce the risk of shortages The international health crisis caused by SARS-CoV-2 and its variants, raised the alert of the sectors connected [...]
Overview of Medicinal Cannabis Cultivation in Brazil
In recent years, issues involving Cannabis-based products for medical purposes are gaining relevance. Today, one of the main access routes to these treatments is through importation [...]
Unique Device Identification (UDI) system and CP no. 1.051/2021
What is the system The Unique Medical Device Identification (UDI)/Unique Device Identification (UDI) System is an international standard that intends to consolidate itself as a global and harmonized system of identification [...]
